President CVPath/Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States
Dr. Finn is an interventional cardiologist and internationally recognized expert in the field of vascular biology and vascular device research. He currently serves as Medical Director and Chief of Research of CVPath and is head of the Institute’s basic and translational research laboratory. He is also an Associate Professor of Medicine at the University of Maryland, where he serves as a cardiologist and interventional cardiologist.
He has published over 150 peer-reviewed research articles, editorials, and reviews and is the recipient of multiple research awards pertaining to his work in vascular biology.
Disclosure(s): Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Science and Myths Behind Device-Based Technology
Sunday, March 8, 2026
8:00 AM - 8:08 AM EST
Vulnerable Plaque 2025 | Where Do We Stand From the Pathologic Perspective?
Sunday, March 8, 2026
3:41 PM - 3:49 PM EST
Sunday, March 8, 2026
7:51 PM - 7:56 PM EST
Panel Discussion: The Future of DCB in the US
Sunday, March 8, 2026
8:04 PM - 8:15 PM EST
Comparing DCB’s | Drug Design Matters – Preclinical
Monday, March 9, 2026
8:00 AM - 8:08 AM EST
Panel Discussion | DCB for Coronary Applications
Monday, March 9, 2026
9:04 AM - 9:20 AM EST
Panel Discussion | Peripheral Vascular Disease DCB, Utility and Safety
Tuesday, March 10, 2026
9:10 AM - 9:40 AM EST